Details of the MenB Vaccination Initiative
A new $4 million initiative by the Tasmanian Government will provide free meningococcal B (MenB) vaccinations from July 2026. Advocacy from the Royal Australian College of General Practitioners (RACGP) played a significant role in this development.
As part of the 2026–27 Budget, catch-up doses will also be available. This year, at least two cases of meningococcal disease were reported in Tasmania, highlighting the need for this initiative.
RACGP Tasmania Chair, Dr Toby Gardner, praised the government for fulfilling a promise made during the 2025 state election by the Tasmanian Liberals. He stated, “It’s great to see this support for families.” The programme marks a crucial step in enhancing healthcare access.
Importance of MenB Vaccination
Meningococcal disease poses a severe threat, causing death in 5-10% of cases and lifelong disability in up to 20%. Over 80% of cases result from the B strain, which wasn’t covered by previous vaccines. The new programme aims to fill this gap.
“A vaccine for the B strain has been available, but at around $140 a dose, it hasn’t been affordable or accessible,” Dr Gardner highlighted. Babies under two years old represent the highest-risk group, significantly concerning families.
Starting in July 2026, the free vaccination programme aims to protect Tasmanian children and reduce the serious illness risk from meningococcal B.
Following the introduction of the MenACWY vaccine for babies and teens, the majority of cases have been attributed to the B strain. This programme specifically addresses the missing link in children’s immunity. Providing free MenB vaccinations is essential for safeguarding young Tasmanians’ health.
This initiative not only fulfills a political promise but also tackles a critical health issue. The state government, along with RACGP, is dedicated to decreasing the incidence of meningococcal disease, which can progress quickly and have devastating consequences.
Last updated: 19 May 2026, 8:20 am
